Bicycle Therapeutics plc— Sankey Diagram
Annual mode · period ending 2026-03-31 · SEC EDGAR
FY2026 - Q4(Jan 26 · Feb 26 · Mar 26)
Total Assets
$652M
↓-26.2% -$231Mvs FY2025
Total Liabilities
$98M
↓-31.7% -$45Mvs FY2025
Equity
$554M
↓-25.1% -$186Mvs FY2025
Cash
$559M
↓-29.4% -$233Mvs FY2025
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $652M | $884M |
| Current Assets | $619M | $856M |
| Cash | $559M | $793M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $136K |
| Inventory | $0 | $0 |
| Other Current | $60M | $63M |
| Non-Current Assets | $33M | $28M |
| PPE | $6M | $9M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $28M | $19M |
| Total Liab+Eq | $652M | $884M |
| Current Liab. | $49M | $58M |
| Accounts Payable | $6M | $11M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $3M | $13M |
| Other CL | $40M | $34M |
| Non-Current Liab. | $49M | $86M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $49M | $86M |
| Equity | $554M | $740M |
| Retained Earnings | $961M | $742M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BCYC · Comparing FY2026 vs FY2025